1 Department of Chest and Tuberculosis.
2 Department of Medicine.
Am J Respir Crit Care Med. 2017 Mar 15;195(6):801-813. doi: 10.1164/rccm.201607-1484OC.
Interstitial lung disease (ILD) is a heterogeneous group of acute and chronic inflammatory and fibrotic lung diseases. Existing ILD registries have had variable findings. Little is known about the clinical profile of ILDs in India.
To characterize new-onset ILDs in India by creating a prospective ILD using multidisciplinary discussion (MDD) to validate diagnoses.
Adult patients of Indian origin living in India with new-onset ILD (27 centers, 19 Indian cities, March 2012-June 2015) without malignancy or infection were included. All had connective tissue disease (CTD) serologies, spirometry, and high-resolution computed tomography chest. ILD pattern was defined by high-resolution computed tomography images. Three groups independently made diagnoses after review of clinical data including that from prompted case report forms: local site investigators, ILD experts at the National Data Coordinating Center (NDCC; Jaipur, India) with MDD, and experienced ILD experts at the Center for ILD (CILD; Seattle, WA) with MDD. Cohen's κ was used to assess reliability of interobserver agreement.
A total of 1,084 patients were recruited. Final diagnosis: hypersensitivity pneumonitis in 47.3% (n = 513; exposure, 48.1% air coolers), CTD-ILD in 13.9%, and idiopathic pulmonary fibrosis in 13.7%. Cohen's κ: 0.351 site investigator/CILD, 0.519 site investigator/NDCC, and 0.618 NDCC/CILD.
Hypersensitivity pneumonitis was the most common new-onset ILD in India, followed by CTD-ILD and idiopathic pulmonary fibrosis; diagnoses varied between site investigators and CILD experts, emphasizing the value of MDD in ILD diagnosis. Prompted case report forms including environmental exposures in prospective registries will likely provide further insight into the etiology and management of ILD worldwide.
间质性肺疾病(ILD)是一组异质性的急性和慢性炎症性及纤维性肺疾病。现有的ILD 登记处的结果存在差异。印度的ILD 临床特征鲜为人知。
通过多学科讨论(MDD)建立ILD 前瞻性研究来验证诊断,以对印度新发 ILD 患者的临床特征进行描述。
纳入 2012 年 3 月至 2015 年 6 月期间,居住在印度的新诊断为ILD 的印度裔成年患者(27 个中心,19 个印度城市),且这些患者无恶性肿瘤或感染。所有患者均进行了结缔组织病(CTD)血清学、肺量测定和高分辨率胸部计算机断层扫描。ILD 模式由高分辨率计算机断层扫描图像定义。在审查包括提示病例报告表中提供的临床数据后,三组独立做出诊断:当地现场调查员、位于印度斋浦尔的国家数据协调中心(NDCC;ILD 专家)的 MDD 组、西雅图华盛顿州的ILD 中心(CILD;ILD 专家)的 MDD 组。使用 Cohen's κ 评估观察者间一致性的可靠性。
共纳入 1084 例患者。最终诊断:47.3%(n=513)为过敏性肺炎(暴露占 48.1%,为空调)、13.9%为 CTD-ILD、13.7%为特发性肺纤维化。Cohen's κ:现场调查员/CILD 为 0.351、现场调查员/NDCC 为 0.519、NDCC/CILD 为 0.618。
过敏性肺炎是印度最常见的新发 ILD,其次是 CTD-ILD 和特发性肺纤维化;现场调查员和 CILD 专家之间的诊断存在差异,这强调了 MDD 在 ILD 诊断中的价值。前瞻性登记处中包括环境暴露的提示病例报告表可能会进一步深入了解ILD 的病因和管理。